FMC Corporation (FMC)
$3.89
-0.40 (-9.32%)Delayed quote.
Price history
Daily close- Start
- $13.18
- Latest close
- $3.90
- Period change
- -70.41%
- Period low
- $3.90
- Period high
- $18.07
Key metrics
- Market cap
- $487.13M
- Volume
- 6.25M
- Average volume
- 5.37M
- 52-week range
- $3.89 – $18.29
- Beta
- 0.50
- Last dividend
- $0.32
- EPS (TTM)
- -$33.04
- P/E ratio
- -0.78
- Revenue (TTM)
- $2.87B
- Net income (TTM)
- -$4.26B
- Total assets
- $7.91B
- Total debt
- $4.30B
- Cash and equivalents
- $735.80M
Key financials (trailing twelve months).
Company profile
FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop protection chemicals, including insecticides, herbicides, and fungicides, alongside biologicals, crop nutrition supplements, and seed treatment solutions. These innovations are employed in farming to boost harvest quantity and quality by mitigating diverse insect infestations, weed growth, and plant ailments. Furthermore, its solutions cater to non-agricultural sectors for general pest control. FMC distributes its comprehensive product range through its proprietary sales teams, in collaboration with alliance partners, and via independent distributors and sales representatives. Established in 1883, FMC Corporation is based in Philadelphia, Pennsylvania, and conducts operations across North America, Latin America, Europe, the Middle East, Africa, and Asia.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Exchange
- NYSE
- CEO
- Pierre R. Brondeau
- Employees
- 5,500
- Headquarters
- Philadelphia, PA, US
- IPO date
- 1980-03-17
- Website
- https://www.fmc.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $3.47B | $4.25B | $4.49B |
| Gross profit | $1.28B | $1.58B | $1.91B |
| Operating income | -$1.89B | $654.70M | $837.90M |
| EBITDA | -$84.70M | $662.70M | $786.20M |
| Net income | -$2.24B | $339.90M | $1.32B |
| Diluted EPS | -$17.88 | $2.72 | $10.51 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $584.50M | $357.30M | $302.40M |
| Total assets | $9.69B | $11.65B | $11.93B |
| Total liabilities | $7.59B | $7.14B | $7.49B |
| Total debt | $4.20B | $3.50B | $4.11B |
| Shareholders’ equity | $2.07B | $4.49B | $4.41B |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | -$80.20M | $671.10M | -$386.40M |
| Capital expenditure | -$96.30M | -$67.90M | -$133.90M |
| Free cash flow | -$176.50M | $603.20M | -$520.30M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $105.90M | $867.10M | $758.60M | $1.14B | $489.00M | $1.05B |
| Gross profit | -$401.60M | $342.10M | $246.60M | $483.00M | $75.70M | $407.30M |
| Operating income | -$631.60M | -$119.70M | -$81.00M | -$1.66B | -$467.30M | $164.10M |
| EBITDA | -$590.70M | -$81.90M | -$42.40M | $96.00M | -$358.50M | $162.70M |
| Net income | -$2.07B | -$186.60M | -$281.30M | -$1.72B | -$569.30M | $66.70M |
| Diluted EPS | -$15.54 | -$1.48 | -$2.25 | -$13.77 | -$4.52 | $0.53 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $735.80M | $476.60M | $390.90M | $584.50M | $497.70M | $438.20M |
| Total assets | $7.91B | $9.14B | $9.42B | $9.69B | $12.08B | $12.30B |
| Total liabilities | $7.90B | $7.48B | $7.57B | $7.59B | $8.28B | $7.87B |
| Total debt | $4.30B | $4.28B | $4.66B | $4.20B | $4.54B | $4.16B |
| Shareholders’ equity | -$19.40M | $1.64B | $1.82B | $2.07B | $3.77B | $4.40B |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$13.30M | $328.70M | -$616.60M | $636.80M | -$208.20M | $49.50M |
| Capital expenditure | -$7.80M | -$5.30M | -$16.60M | -$26.00M | -$23.70M | -$15.00M |
| Free cash flow | -$21.10M | $323.40M | -$633.20M | $610.80M | -$231.90M | $34.50M |